WASHINGTON - The largest-ever outbreak of Ebola could drain billions of dollars from economies in West Africa by the end of next year if the epidemic is not contained, the World Bank said in an analysis on Wednesday.
LONDON - The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organizers said.
- Merck & Co Inc said it had licensed its experimental psoriasis drug to Indian generic maker Sun Pharmaceutical Industries Ltd for $80 million.
LONDON - Roche Chief Executive Severin Schwan likes to crack open the champagne with his drug research teams at the end of a big project - especially when they fail.
- Over the last several months there has been a 'plateau and downward trend' in the use of Gilead Sciences Inc's controversial $1,000-a-pill hepatitis C treatment, Sovaldi, a CVS Health Corp analysis showed.
- Gilead Sciences Inc said its experimental drug did not significantly improve how long patients with a type of pancreatic cancer lived without the disease worsening.
- Auxilium Pharmaceuticals Inc said it would not withdraw its offer to buy Canadian eye drug maker QLT Inc and adopted a poison pill, a day after receiving an unsolicited buyout offer from Endo International Plc.
NEW YORK - A campaign by 16 of the world's largest food and beverage companies to dramatically cut the number of calories sold in the United States may have stalled after initial success, researchers reported on Wednesday.
ATLANTA/MONROVIA - President Barack Obama on Tuesday called West Africa's deadly Ebola outbreak a looming threat to global security and announced a major expansion of the U.S. role in trying to halt its spread, including deployment of 3,000 troops to the region. | Video
MUMBAI - Indian generic drugmaker Ranbaxy Laboratories Ltd said on Wednesday that federal authorities in the United States had sought details on how it reports pricing data for some products eligible for reimbursement under the Medicaid program.
Video: Health Reform Watch
A series that looks at all facets of cancer, written by Debra Sherman, a lung cancer patient who succumbed to the disease on April 22, 2014. Debra covered the health beat for Reuters for more than a decade and drew on her knowledge about health, her contacts in the industry and her personal experiences to report this series. Full Article